Evidence map›Paper›PMID 40001639›Full record

ArticleBioengineering (Basel, Switzerland)2025

Deep Learning-Enhanced Portable Chemiluminescence Biosensor: 3D-Printed, Smartphone-Integrated Platform for Glucose Detection.

Chirag M Singhal, Vani Kaushik, Abhijeet Awasthi, Jitendra B Zalke, Sangeeta Palekar, Prakash Rewatkar, Sanjeet Kumar Srivastava, Madhusudan B Kulkarni, Manish L Bhaiyya

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chirag M SinghalDepartment of Electronics Engineering (Biomedical Engineering), Ramdeobaba University, Nagpur 440013, India.ORCID 0009-0005-4497-4055
Vani KaushikDepartment of Electronics Engineering (Biomedical Engineering), Ramdeobaba University, Nagpur 440013, India.
Abhijeet AwasthiDepartment of Electronics Engineering (Biomedical Engineering), Ramdeobaba University, Nagpur 440013, India.
Jitendra B ZalkeDepartment of Electronics Engineering, Ramdeobaba University, Nagpur 440013, India.ORCID 0000-0002-5382-3508
Sangeeta PalekarBio Spectronics Private Limited, Nagpur 440013, India.
Prakash RewatkarDepartment of Mechanical Engineering, Technion, Israel Institute of Technology, Haifa 3200003, Israel.
Sanjeet Kumar SrivastavaDepartment of Electrical & Electronics Engineering, Birla Institute of Technology & Science Pilani, Hyderabad Campus, Hyderabad 500078, India.
Madhusudan B KulkarniDepartment of Electronics and Communication Engineering, Manipal Institute of Technology, Manipal Academy of Higher Education (MAHE), Manipal 576104, India.ORCID 0000-0002-2911-3784
Manish L BhaiyyaDepartment of Electronics Engineering, Ramdeobaba University, Nagpur 440013, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel, portable chemiluminescence (CL) sensing platform powered by deep learning and smartphone integration has been developed for cost-effective and selective glucose detection. This platform features low-cost, wax-printed micro-pads (WPµ-pads) on paper-based substrates used to construct a miniaturized CL sensor. A 3D-printed black box serves as a compact WPµ-pad sensing chamber, replacing traditional bulky equipment, such as charge coupled device (CCD) cameras and optical sensors. Smartphone integration enables a seamless and user-friendly diagnostic experience, making this platform highly suitable for point-of-care (PoC) applications. Deep learning models significantly enhance the platform's performance, offering superior accuracy and efficiency in CL image analysis. A dataset of 600 experimental CL images was utilized, out of which 80% were used for model training, with 20% of the images reserved for testing. Comparative analysis was conducted using multiple deep learning models, including Random Forest, the Support Vector Machine (SVM), InceptionV3, VGG16, and ResNet-50, to identify the optimal architecture for accurate glucose detection. The CL sensor demonstrates a linear detection range of 10-1000 µM, with a low detection limit of 8.68 µM. Extensive evaluations confirmed its stability, repeatability, and reliability under real-world conditions. This deep learning-powered platform not only improves the accuracy of analyte detection, but also democratizes access to advanced diagnostics through cost-effective and portable technology. This work paves the way for next-generation biosensing, offering transformative potential in healthcare and other domains requiring rapid and reliable analyte detection.

Indexed as

3D-printed sensorbio-analyte detectionchemiluminescence detectiondeep learningpaper-based WPµ-padpoint-of-care (PoC) diagnosticsportable biosensorsmartphone integration

Identifiers

PMID40001639
PMCPMC11851613

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.